PDF
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Mid Cap Stockholm |
| Sektor | Hälsovård |
| Industri | Vård & Omsorg |
Continuing improvements in Sweden and Norway
Summary of the second quarter
Net revenue was SEK 2,506 million (2,534).
Organic growth was -1.5 percent (1.3).
Operating profit was SEK 75m (80).
Adjusted operating profit amounted to SEK 77m (107).
Net profit after tax for the period amounted to SEK 17m (0).
Earnings per share for the period amounted to SEK 0.31 (0.01).
Cash flow for the period amounted to SEK -26m (-229).
Free cash flow amounted to SEK 107m (19).
Summary of the six-month period
Net revenue was SEK 5,039 million (4,942).
Organic growth was -1.8 percent (0.1).
Operating profit was SEK 218m (167).
Adjusted operating profit amounted to SEK 185m (207).
Net profit after tax for the period amounted to SEK 91m (21).
Earnings per share for the period amounted to SEK 1.77 (0.44).
Cash flow for the period amounted to SEK 82m (-287).
Free cash flow amounted to SEK 58m (-39).
Significant events in the second quarter of 2025 and after the reporting period
In February and March 2025, the Board decided to exercise the authority granted to it by the 2024 annual general meeting (AGM) to buy back 2,000,000 shares. On 9 May, Humana announced that the buyback programme had been concluded. Subsequently, the company's holding of own shares amounted to 1,985,273 shares, which is 3.8 percent of the total number of shares and votes. After the buyback, the total number of shares excluding own shares is 49,840,785.
On 14 July, Humana signed a new loan agreement, which will result in the refinancing of existing loans, of SEK 2.3 billion. The current lower base rates, lower overall credit limit, revised loan structure with a higher proportion of revolving variable credits and a lower proportion of loans, combined with lower interest margins, are collectively expected to help reduce Humana's annual net interest income by approximately SEK 35m, all other factors being equal, compared with the most recent 12-month period. The financial agreement is a three-year loan agreement, with two extension options of one year each, with four Nordic banks.
President and CEO Nathalie Boulas Nilsson comments on the quarter
We continue to build strong foundations for profitable growth. Adjusted for calendar effects, further improvements were apparent in Sweden and Norway during the quarter. Market conditions in Finland are challenging, and our streamlining measures will have an effect in the third quarter of the year. With a new long-term loan agreement in place, a strong financial position, combined with numerous initiatives to promote growth within our strategically prioritised areas, we are in a strong position to accelerate the rate of growth and boost profitability.
Read the full comment in the report.
Conference call
A webcast will be held on 18 july 2025 at 09:00 CET at which President and CEO Nathalie Boulas Nilsson and CFO Christoffer Herou will present the report and answer questions. If you wish to take part via the webcast, use the following link.
If you wish to participate via conference call, please register on the link below. After registration you will be provided phone numbers and a conference ID to access the conference. You can ask questions verbally via the conference call.
For more information, please contact:
Christoffer Herou
CFO
+46 72 582 86 16, christoffer.herou@humana.se
Ewelina Pettersson
Head of investor relations
+46 73 074 79 12, ewelina.pettersson@humana.se
This disclosure contains information that Humana AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014) and the Swedish Securities Markets Act (2007:528). The information was submitted for publication, through the agency of the contact person, on 18-07-2025 08:00 CET.